Physician profile
Siji Thomas
NPI 1417359761
$1,589.99
in general payments reported to CMS, 2019-2025
9 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $31.59 · 2023: $138 · 2024: $690 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $581.82 | 2021-2024 | Xarelto |
| Amarin Pharma, INC. | $247.19 | 2024-2025 | Vascepa |
| Abiomed | $175.55 | 2024-2025 | Impella |
| Heartflow, INC. | $142.18 | 2024 | |
| Alnylam Pharmaceuticals INC. | $126.75 | 2025 | Amvuttra |
| Amgen INC. | $125.00 | 2024 | Repatha |
| Ardelyx, INC. | $121.84 | 2024 | Xphozah 30 Mg |
| Boston Scientific Corporation | $38.07 | 2023-2024 | Comet, Opticross |
| Biotronik INC. | $31.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siji Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.